Nexalis Therapeutics Limited has released a press release.
Quarter 4 Update
Filed with ASX ·
On 6ix: 6ix.com/news/quarter-4-update
6ix hasn’t read this filing yet.
Nexalis Therapeutics Limited on 6ix
Earlier from Nexalis Therapeutics
- Placement of Rights Issue Shortfall
- Rights Issue Offer Document
- Non-renounceable rights issue
- $720,500 Private Placement
- Quarter 3 Update
Later from Nexalis Therapeutics
- Quarter 1 Update
- Appendix 4C - quarterly
- Quarter 2 Update
- Appendix 4C Cash Flow Report
- InhaleRx Ltd appoints Executive Director
Follow Nexalis Therapeutics into a list and get an email when it puts out news.
Follow Nexalis Therapeutics